 Nicole Tartaglia
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Klinefelter Syndrome | 15 | 2021 | 53 | 6.050 |
Why?
| | Trisomy | 18 | 2022 | 66 | 4.640 |
Why?
| | Sex Chromosome Aberrations | 18 | 2023 | 53 | 3.980 |
Why?
| | Sex Chromosomes | 18 | 2022 | 48 | 3.080 |
Why?
| | Sex Chromosome Disorders of Sex Development | 5 | 2020 | 8 | 2.880 |
Why?
| | Aneuploidy | 12 | 2022 | 88 | 2.790 |
Why?
| | Sex Chromosome Disorders | 7 | 2020 | 13 | 2.430 |
Why?
| | Autism Spectrum Disorder | 7 | 2022 | 323 | 2.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 9 | 2022 | 366 | 1.890 |
Why?
| | XYY Karyotype | 10 | 2022 | 15 | 1.830 |
Why?
| | Fragile X Syndrome | 14 | 2022 | 80 | 1.780 |
Why?
| | Chromosomes, Human, X | 11 | 2023 | 58 | 1.730 |
Why?
| | Prenatal Diagnosis | 6 | 2022 | 168 | 1.330 |
Why?
| | Child | 44 | 2022 | 19129 | 0.950 |
Why?
| | Developmental Disabilities | 5 | 2016 | 247 | 0.900 |
Why?
| | Phenotype | 12 | 2016 | 3003 | 0.840 |
Why?
| | Child, Preschool | 29 | 2022 | 9491 | 0.770 |
Why?
| | Chromosomes, Human, Y | 3 | 2009 | 15 | 0.770 |
Why?
| | Ovarian Reserve | 1 | 2020 | 13 | 0.750 |
Why?
| | Cognition Disorders | 5 | 2021 | 529 | 0.750 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2020 | 30 | 0.740 |
Why?
| | Adolescent | 28 | 2022 | 18480 | 0.680 |
Why?
| | Motor Skills Disorders | 1 | 2018 | 19 | 0.680 |
Why?
| | Genetic Association Studies | 2 | 2021 | 371 | 0.670 |
Why?
| | Turner Syndrome | 1 | 2019 | 50 | 0.650 |
Why?
| | Neuropsychological Tests | 12 | 2022 | 1032 | 0.650 |
Why?
| | Child Behavior | 5 | 2017 | 212 | 0.650 |
Why?
| | Truth Disclosure | 2 | 2016 | 38 | 0.640 |
Why?
| | Child Development Disorders, Pervasive | 5 | 2012 | 61 | 0.630 |
Why?
| | Students | 1 | 2022 | 509 | 0.610 |
Why?
| | Chromosome Disorders | 2 | 2014 | 39 | 0.600 |
Why?
| | Genetic Testing | 4 | 2021 | 389 | 0.600 |
Why?
| | Adaptation, Physiological | 1 | 2020 | 502 | 0.560 |
Why?
| | Parents | 3 | 2020 | 1212 | 0.560 |
Why?
| | Executive Function | 4 | 2022 | 391 | 0.550 |
Why?
| | Cognition | 8 | 2022 | 1024 | 0.540 |
Why?
| | Humans | 65 | 2023 | 118974 | 0.540 |
Why?
| | Karyotyping | 4 | 2020 | 102 | 0.530 |
Why?
| | Male | 45 | 2023 | 57801 | 0.500 |
Why?
| | Young Adult | 14 | 2021 | 10793 | 0.450 |
Why?
| | Testosterone | 2 | 2020 | 351 | 0.440 |
Why?
| | Infant | 18 | 2022 | 8293 | 0.440 |
Why?
| | Parent-Child Relations | 1 | 2014 | 232 | 0.420 |
Why?
| | Autistic Disorder | 4 | 2020 | 168 | 0.420 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 942 | 0.410 |
Why?
| | Language Development Disorders | 3 | 2019 | 40 | 0.410 |
Why?
| | Adolescent Development | 1 | 2012 | 84 | 0.400 |
Why?
| | Abnormalities, Multiple | 3 | 2012 | 181 | 0.380 |
Why?
| | Female | 28 | 2023 | 61565 | 0.380 |
Why?
| | Tremor | 2 | 2009 | 46 | 0.370 |
Why?
| | Hormone Replacement Therapy | 1 | 2010 | 80 | 0.360 |
Why?
| | Obesity | 2 | 2020 | 2746 | 0.360 |
Why?
| | Attention | 5 | 2022 | 408 | 0.330 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 1798 | 0.330 |
Why?
| | Adult | 20 | 2022 | 31512 | 0.320 |
Why?
| | Adolescent Behavior | 2 | 2012 | 482 | 0.310 |
Why?
| | Emotions | 3 | 2022 | 495 | 0.310 |
Why?
| | Child Development | 1 | 2012 | 410 | 0.310 |
Why?
| | Fragile X Mental Retardation Protein | 5 | 2022 | 65 | 0.280 |
Why?
| | Perceptual Disorders | 2 | 2019 | 21 | 0.270 |
Why?
| | Case-Control Studies | 4 | 2020 | 3171 | 0.260 |
Why?
| | DiGeorge Syndrome | 2 | 2019 | 21 | 0.260 |
Why?
| | Space Perception | 2 | 2019 | 65 | 0.260 |
Why?
| | Pregnancy | 3 | 2022 | 5691 | 0.250 |
Why?
| | Child Behavior Disorders | 3 | 2016 | 129 | 0.250 |
Why?
| | Y Chromosome | 1 | 2023 | 6 | 0.240 |
Why?
| | Visual Perception | 2 | 2019 | 141 | 0.240 |
Why?
| | Comorbidity | 5 | 2022 | 1527 | 0.240 |
Why?
| | Behavior | 2 | 2019 | 95 | 0.240 |
Why?
| | Cell Adhesion Molecules, Neuronal | 2 | 2015 | 35 | 0.230 |
Why?
| | Syndrome | 4 | 2020 | 344 | 0.230 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2001 | 117 | 0.230 |
Why?
| | Behavioral Symptoms | 2 | 2022 | 44 | 0.230 |
Why?
| | Seizures | 4 | 2022 | 345 | 0.230 |
Why?
| | Genetic Counseling | 2 | 2016 | 66 | 0.230 |
Why?
| | Mitral Valve Prolapse | 1 | 2022 | 8 | 0.220 |
Why?
| | Puberty | 2 | 2016 | 144 | 0.220 |
Why?
| | Social Change | 1 | 2022 | 12 | 0.210 |
Why?
| | Social Behavior | 3 | 2022 | 276 | 0.210 |
Why?
| | Theory of Mind | 1 | 2022 | 9 | 0.210 |
Why?
| | Cannabidiol | 1 | 2022 | 53 | 0.210 |
Why?
| | Calcium-Binding Proteins | 2 | 2012 | 217 | 0.210 |
Why?
| | Cross-Sectional Studies | 6 | 2022 | 4552 | 0.200 |
Why?
| | Mental Disorders | 2 | 2017 | 939 | 0.200 |
Why?
| | Surveys and Questionnaires | 5 | 2022 | 4708 | 0.200 |
Why?
| | Food, Formulated | 1 | 2020 | 19 | 0.190 |
Why?
| | Cyclic AMP | 1 | 2001 | 242 | 0.190 |
Why?
| | Gonadotropins | 1 | 2020 | 37 | 0.190 |
Why?
| | Glutamates | 1 | 2020 | 60 | 0.180 |
Why?
| | Toilet Training | 1 | 2019 | 3 | 0.180 |
Why?
| | Anti-Mullerian Hormone | 1 | 2020 | 51 | 0.180 |
Why?
| | Educational Status | 1 | 2022 | 437 | 0.180 |
Why?
| | Time Perception | 1 | 2019 | 23 | 0.180 |
Why?
| | Waist Circumference | 1 | 2020 | 130 | 0.180 |
Why?
| | Mathematical Concepts | 1 | 2019 | 24 | 0.180 |
Why?
| | Infant Formula | 1 | 2020 | 84 | 0.180 |
Why?
| | Hippocampus | 2 | 2001 | 735 | 0.180 |
Why?
| | Counseling | 1 | 2022 | 353 | 0.180 |
Why?
| | Intelligence | 1 | 2020 | 136 | 0.180 |
Why?
| | Irritable Mood | 1 | 2019 | 51 | 0.170 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 71 | 0.170 |
Why?
| | Problem Behavior | 1 | 2020 | 85 | 0.170 |
Why?
| | Auditory Perception | 1 | 2019 | 106 | 0.170 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 131 | 0.170 |
Why?
| | Synapses | 2 | 2001 | 344 | 0.170 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 187 | 0.170 |
Why?
| | Face | 1 | 2020 | 165 | 0.170 |
Why?
| | Neurodevelopmental Disorders | 1 | 2020 | 116 | 0.160 |
Why?
| | Mosaicism | 2 | 2016 | 62 | 0.160 |
Why?
| | Self-Injurious Behavior | 1 | 2019 | 120 | 0.160 |
Why?
| | Aggression | 1 | 2019 | 183 | 0.160 |
Why?
| | Triglycerides | 1 | 2020 | 519 | 0.160 |
Why?
| | Memory, Short-Term | 1 | 2020 | 233 | 0.160 |
Why?
| | Prader-Willi Syndrome | 1 | 2017 | 27 | 0.150 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 193 | 0.150 |
Why?
| | Oxandrolone | 1 | 2017 | 8 | 0.150 |
Why?
| | Eosinophilic Esophagitis | 1 | 2021 | 308 | 0.150 |
Why?
| | Estradiol | 1 | 2020 | 476 | 0.150 |
Why?
| | Disability Evaluation | 1 | 2018 | 280 | 0.150 |
Why?
| | Hypersensitivity | 1 | 2020 | 268 | 0.150 |
Why?
| | Facies | 1 | 2016 | 22 | 0.150 |
Why?
| | Cohort Studies | 3 | 2020 | 5116 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 499 | 0.140 |
Why?
| | X Chromosome Inactivation | 1 | 2016 | 21 | 0.140 |
Why?
| | Down Syndrome | 2 | 2013 | 356 | 0.140 |
Why?
| | Speech Disorders | 1 | 2016 | 35 | 0.140 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 394 | 0.140 |
Why?
| | Testis | 1 | 2016 | 144 | 0.140 |
Why?
| | Transcription Factors | 1 | 2023 | 1570 | 0.130 |
Why?
| | Androgens | 1 | 2017 | 167 | 0.130 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2674 | 0.130 |
Why?
| | Registries | 2 | 2020 | 1810 | 0.130 |
Why?
| | Physical Examination | 1 | 2016 | 243 | 0.130 |
Why?
| | Nerve Tissue Proteins | 3 | 2012 | 551 | 0.130 |
Why?
| | Neuroimaging | 1 | 2016 | 256 | 0.120 |
Why?
| | Muscle Strength | 1 | 2017 | 283 | 0.120 |
Why?
| | Trisomy 13 Syndrome | 1 | 2013 | 3 | 0.110 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2013 | 18 | 0.110 |
Why?
| | Polymorphism, Genetic | 1 | 2016 | 642 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2275 | 0.110 |
Why?
| | Self Concept | 1 | 2014 | 215 | 0.110 |
Why?
| | Tetrasomy | 1 | 2012 | 3 | 0.110 |
Why?
| | Body Mass Index | 1 | 2020 | 2092 | 0.110 |
Why?
| | Wechsler Scales | 1 | 2012 | 57 | 0.110 |
Why?
| | Exons | 1 | 2012 | 307 | 0.100 |
Why?
| | Trinucleotide Repeat Expansion | 2 | 2008 | 26 | 0.100 |
Why?
| | Hypogonadism | 1 | 2011 | 77 | 0.100 |
Why?
| | Intellectual Disability | 1 | 2012 | 136 | 0.100 |
Why?
| | Gene Deletion | 1 | 2012 | 361 | 0.090 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2012 | 499 | 0.090 |
Why?
| | Data Collection | 1 | 2013 | 658 | 0.090 |
Why?
| | Nonlinear Dynamics | 1 | 2010 | 89 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1597 | 0.090 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2008 | 122 | 0.090 |
Why?
| | Body Height | 1 | 2010 | 187 | 0.090 |
Why?
| | Language Disorders | 1 | 2009 | 32 | 0.080 |
Why?
| | Prospective Studies | 1 | 2020 | 6471 | 0.080 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2008 | 39 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1185 | 0.080 |
Why?
| | Chromosome Deletion | 1 | 2008 | 95 | 0.080 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2008 | 68 | 0.080 |
Why?
| | Middle Aged | 6 | 2019 | 27617 | 0.080 |
Why?
| | Psychomotor Performance | 1 | 2009 | 290 | 0.070 |
Why?
| | Genotype | 1 | 2012 | 1882 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 9000 | 0.070 |
Why?
| | United States | 1 | 2022 | 12555 | 0.070 |
Why?
| | Vagus Nerve | 2 | 1997 | 80 | 0.070 |
Why?
| | Prevalence | 2 | 2021 | 2326 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2020 | 1687 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2174 | 0.060 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2003 | 64 | 0.060 |
Why?
| | Gene Duplication | 1 | 2003 | 64 | 0.060 |
Why?
| | Time Factors | 2 | 2013 | 6412 | 0.060 |
Why?
| | Muscle Hypotonia | 2 | 2013 | 31 | 0.060 |
Why?
| | Interleukin-1 | 3 | 1997 | 980 | 0.060 |
Why?
| | Gels | 1 | 2022 | 72 | 0.050 |
Why?
| | Mental Status and Dementia Tests | 1 | 2022 | 21 | 0.050 |
Why?
| | Anxiety | 2 | 2020 | 845 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 3 | 2010 | 310 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2013 | 5255 | 0.050 |
Why?
| | Abnormal Karyotype | 1 | 2021 | 2 | 0.050 |
Why?
| | Synaptotagmins | 1 | 2001 | 21 | 0.050 |
Why?
| | Vocabulary | 1 | 2021 | 42 | 0.050 |
Why?
| | Synaptic Vesicles | 1 | 2001 | 38 | 0.050 |
Why?
| | Mutation | 2 | 2009 | 3457 | 0.050 |
Why?
| | Rats | 5 | 2001 | 5392 | 0.050 |
Why?
| | Long-Term Potentiation | 1 | 2001 | 148 | 0.050 |
Why?
| | Risperidone | 1 | 2019 | 27 | 0.040 |
Why?
| | Language | 1 | 2022 | 271 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1094 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2001 | 446 | 0.040 |
Why?
| | Gene Expression | 1 | 2023 | 1489 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 503 | 0.040 |
Why?
| | Antidepressive Agents | 1 | 2019 | 189 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1384 | 0.040 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 219 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2021 | 12978 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2017 | 139 | 0.030 |
Why?
| | Communication | 1 | 2022 | 761 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 228 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2513 | 0.030 |
Why?
| | Animals | 7 | 2017 | 33381 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2021 | 829 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 1781 | 0.030 |
Why?
| | Metformin | 1 | 2017 | 295 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2017 | 345 | 0.030 |
Why?
| | Hand Deformities | 1 | 2013 | 2 | 0.030 |
Why?
| | Megalencephaly | 1 | 2013 | 15 | 0.030 |
Why?
| | Fever | 1 | 1995 | 283 | 0.030 |
Why?
| | Research | 1 | 2016 | 411 | 0.030 |
Why?
| | Brain | 2 | 1995 | 2490 | 0.030 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2012 | 24 | 0.030 |
Why?
| | Taste | 1 | 1995 | 218 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2012 | 124 | 0.030 |
Why?
| | Social Class | 1 | 2013 | 218 | 0.030 |
Why?
| | Introns | 1 | 2012 | 234 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2012 | 167 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2012 | 345 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 4 | 1999 | 2478 | 0.020 |
Why?
| | Short Stature Homeobox Protein | 1 | 2010 | 1 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2017 | 9342 | 0.020 |
Why?
| | Esophagitis | 1 | 2010 | 66 | 0.020 |
Why?
| | Gene Dosage | 1 | 2010 | 136 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2009 | 90 | 0.020 |
Why?
| | Depression | 1 | 2017 | 1132 | 0.020 |
Why?
| | Trinucleotide Repeats | 1 | 2008 | 24 | 0.020 |
Why?
| | DNA Repeat Expansion | 1 | 2008 | 5 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2008 | 30 | 0.020 |
Why?
| | Ataxia | 1 | 2008 | 38 | 0.020 |
Why?
| | Chromosome Aberrations | 1 | 2008 | 136 | 0.020 |
Why?
| | Physicians | 1 | 2016 | 794 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2010 | 237 | 0.020 |
Why?
| | Fibromyalgia | 1 | 2008 | 56 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 287 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1012 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2009 | 267 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2010 | 468 | 0.020 |
Why?
| | Heterozygote | 1 | 2007 | 262 | 0.020 |
Why?
| | Signal Transduction | 1 | 1999 | 4709 | 0.020 |
Why?
| | Quality of Life | 1 | 2016 | 2366 | 0.020 |
Why?
| | Vagotomy | 2 | 1995 | 34 | 0.020 |
Why?
| | Stereotypic Movement Disorder | 1 | 2003 | 7 | 0.010 |
Why?
| | Pedigree | 1 | 2003 | 485 | 0.010 |
Why?
| | Mass Screening | 1 | 2007 | 1052 | 0.010 |
Why?
| | Phospholipase C gamma | 1 | 1999 | 25 | 0.010 |
Why?
| | Type C Phospholipases | 1 | 1999 | 66 | 0.010 |
Why?
| | Hypertension | 1 | 2008 | 1203 | 0.010 |
Why?
| | Electrophysiology | 1 | 1999 | 204 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 175 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 297 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1999 | 341 | 0.010 |
Why?
| | Histocytochemistry | 1 | 1997 | 82 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1999 | 806 | 0.010 |
Why?
| | Saccharin | 1 | 1995 | 4 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 1945 | 0.010 |
Why?
| | Stress, Physiological | 1 | 1995 | 415 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1995 | 1171 | 0.010 |
Why?
| | Aged | 1 | 2008 | 19657 | 0.010 |
Why?
| | Cytokines | 1 | 1995 | 1900 | 0.000 |
Why?
|
|
Tartaglia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|